Pharmaceuticals : Shots - Health News Pharmaceuticals

Speaker of the House Paul Ryan, center, and other lawmakers have a plan to overhaul the tax code that includes a provision that would repeal a tax credit for makers of drugs for rare diseases. Alex Wong/Getty Images hide caption

toggle caption
Alex Wong/Getty Images

Republican Sen. Charles Grassley of Iowa and Democratic Sen. Amy Klobuchar of Minnesota want drugmakers to stop wasting money by making eyedrops that are too big. Douglas Graham/CQ-Roll Call Inc./Getty Images hide caption

toggle caption
Douglas Graham/CQ-Roll Call Inc./Getty Images

Gregory Matthews has glaucoma and uses prescription eyedrops. The dropper's opening creates a bigger drop than he needs, causing him to run out of his medication before the prescription is ready to refill. Matt Roth for ProPublica hide caption

toggle caption
Matt Roth for ProPublica

Drug Companies Make Eyedrops Too Big, And You Pay For The Waste

  • Download
  • <iframe src="https://www.npr.org/player/embed/558358137/558706881" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Drug lobbyists and consumer health advocates fill the halls of the state Capitol in September to see how Assembly members vote on a controversial drug price transparency bill. Tam Ma/Courtesy of Health Access California hide caption

toggle caption
Tam Ma/Courtesy of Health Access California

California Bill Would Compel Drugmakers To Justify Price Hikes

  • Download
  • <iframe src="https://www.npr.org/player/embed/551013546/555710534" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Hepatitis C virus, via transmission electron microscopy. (The actual viral diameter is around 22 nm.) Doctors say the recent FDA approval of Mavyret, a less expensive drug for treating the virus, may make it easier for more insurers and correctional facilities to expand treatment. James Cavallini/Science Source hide caption

toggle caption
James Cavallini/Science Source

A study of chemotherapy medicines produced by 10 companies found that, on average, each drug produced seven times as much revenue for its manufacturer as it cost in research and development. BrianAJackson/iStockphoto/Getty Images hide caption

toggle caption
BrianAJackson/iStockphoto/Getty Images

R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds

  • Download
  • <iframe src="https://www.npr.org/player/embed/550135932/550218516" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Avi Ofer for NPR

How Moldy Hay And Sick Cows Led To A Lifesaving Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/531749974/547099694" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Judge Lewis Gregory, head of the city court in Greenwood, Ind., began allowing drug court participants to begin taking Vivitrol after meeting with an Alkermes sales representative. Jake Harper/Side Effects Public Media hide caption

toggle caption
Jake Harper/Side Effects Public Media

To Grow Market Share, A Drugmaker Pitches Its Product To Judges

  • Download
  • <iframe src="https://www.npr.org/player/embed/540029500/541304567" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Vicki Reid, right, holds a likeness of John Martin, who was then CEO of the pharmaceutical company Gilead Sciences. Reid and others were protesting high drug prices in front of the conference on retroviruses and opportunistic infections — a meeting held at the World Congress Center in Atlanta in March 2013. John Amis/AP Images for AIDS Healthcare Foundation hide caption

toggle caption
John Amis/AP Images for AIDS Healthcare Foundation

As Cost Of U.S. Health Care Skyrockets, So Does Pay Of Health Care CEOs

  • Download
  • <iframe src="https://www.npr.org/player/embed/539518682/539576211" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The anti-inflammatory drug Bextra was taken off the market because it increased the risk of heart attack and stroke. Tannen Maury/Bloomberg via Getty Images hide caption

toggle caption
Tannen Maury/Bloomberg via Getty Images

Postpartum hemorrhage is the leading cause of maternal deaths around the world. Thomas Fredberg/Getty Images/Science Photo Library hide caption

toggle caption
Thomas Fredberg/Getty Images/Science Photo Library

Overlooked Drug Could Save Thousands Of Moms After Childbirth

  • Download
  • <iframe src="https://www.npr.org/player/embed/525639110/525764774" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An organization campaigning against foreign drug imports has deep connections to the lobbying group PhRMA, which includes Eli Lilly, Pfizer and Bayer. Bill Diodato/Getty Images hide caption

toggle caption
Bill Diodato/Getty Images

Using surrogate endpoints can speed up testing of new drugs, but doesn't always find out if they actually help patients. Getty Images/iStockphoto hide caption

toggle caption
Getty Images/iStockphoto